Thyrocare Technologies Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

195.53

216.53

193.03

187.16

165.92

177.36

156.91

Other Operating Income

0.00

Total Operating income

195.53

216.53

193.03

187.16

165.92

177.36

156.91

Raw Material Cost

47.07

59.81

55.41

48.71

44.79

50.12

44.65

Purchase of Finished goods

0.04

0.21

0.07

0.46

0.20

1.28

0.06

(Increase) / Decrease In Stocks

0.09

0.04

0.15

0.30

0.17

-0.41

0.75

Employee Cost

35.76

33.23

33.00

33.47

35.09

29.49

28.72

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

54.74

51.89

46.63

46.52

43.94

48.59

40.09

Total Expenditure (Excl Depreciation)

137.70

145.18

135.26

129.46

124.19

129.07

114.27

Operating Profit (PBDIT) excl Other Income

57.83

71.35

57.77

57.70

41.73

48.29

42.64

Other Income

4.98

3.05

4.65

4.59

4.01

2.61

3.61

Operating Profit (PBDIT)

62.81

74.40

62.42

62.29

45.74

50.90

46.25

Interest

-0.09

0.59

0.78

0.70

0.60

0.76

0.99

Exceptional Items

-6.16

0.00

Gross Profit (PBDT)

56.74

73.81

61.64

61.59

45.14

50.14

45.26

Depreciation

21.63

11.51

11.41

13.77

17.06

13.07

11.36

Profit Before Tax

35.39

62.58

50.48

47.19

27.92

36.78

33.55

Tax

7.34

14.77

12.19

25.62

8.97

10.36

9.61

Provisions and contingencies

0.00

Profit After Tax

27.77

47.53

38.04

22.20

19.11

26.71

24.29

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

27.77

47.53

38.04

22.20

19.11

26.71

24.29

Share in Profit of Associates

0.28

0.25

-0.63

-0.16

-0.29

-0.35

Minority Interest

-0.96

-0.18

-0.64

-0.13

-0.16

-0.25

-0.23

Other related items

0.00

Consolidated Net Profit

29.01

47.99

38.93

21.70

19.11

26.67

24.17

Equity Capital

159.16

52.99

52.95

Face Value

10.0

Reserves

0.00

Earnings per share (EPS)

1.82

3.02

7.35

4.1

1.2

5.04

4.56

Diluted Earnings per share

1.81

3.01

7.33

4.17

1.19

4.99

4.51

Operating Profit Margin (Excl OI)

29.58%

32.95%

29.93%

30.83%

25.15%

27.23%

27.17%

Gross Profit Margin

29.02%

34.09%

31.93%

32.91%

27.21%

28.27%

28.84%

PAT Margin

14.35%

22.08%

19.84%

11.52%

11.42%

14.9%

15.26%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is 17.85% vs 23.14% in Dec 2024

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 51.81% vs 24.50% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 38.58% vs 32.10% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is -115.00% vs -43.93% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Thyrocare Tech. With

Select Peers

Figures in Cr

Consolidate Quarterly Results

Change(INR)

Change(%)

Net Sales

195.53

429.19

-233.66

-54.44%

Other Operating Income

0.00

Total Operating income

195.53

429.19

-233.66

-54.44%

Raw Material Cost

47.07

87.75

-40.68

-46.36%

Purchase of Finished goods

0.04

0.00

0.04

(Increase) / Decrease In Stocks

0.09

0.00

0.09

Employee Cost

35.76

95.39

-59.63

-62.51%

Power Cost

0.00

Manufacturing Expenses

0.00

4.97

-4.97

-100.00%

Selling and Distribution Expenses

0.00

Other Expenses

54.74

132.85

-78.11

-58.80%

Total Expenditure (Excl Depreciation)

137.70

320.96

-183.26

-57.10%

Operating Profit (PBDIT) excl Other Income

57.83

108.23

-50.40

-46.57%

Other Income

4.98

0.89

4.09

459.55%

Operating Profit (PBDIT)

62.81

109.12

-46.31

-42.44%

Interest

-0.09

5.68

-5.77

-101.58%

Exceptional Items

-6.16

0.00

-6.16

Gross Profit (PBDT)

56.74

103.44

-46.70

-45.15%

Depreciation

21.63

32.41

-10.78

-33.26%

Profit Before Tax

35.39

71.03

-35.64

-50.18%

Tax

7.34

18.14

-10.80

-59.54%

Provisions and contingencies

0.00

Profit After Tax

27.77

52.89

-25.12

-47.49%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

27.77

52.89

-25.12

-47.49%

Share in Profit of Associates

0.28

0.00

0.28

Minority Interest

-0.96

0.22

-1.18

-536.36%

Other related items

0.00

Consolidated Net Profit

29.01

52.67

-23.66

-44.92%

Equity Capital

159.16

10.36

148.80

1,436.29%

Face Value

10.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

1.82

10.17

-8.35

-82.10%

Diluted Earnings per share

1.81

10.13

-8.32

-82.13%

Operating Profit Margin (Excl OI)

29.58%

25.22%

0.00

4.36%

Gross Profit Margin

29.02%

24.10%

0.00

4.92%

PAT Margin

14.35%

12.32%

0.00

2.03%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 195.53 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -9.70% vs 12.17% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 17.85% vs 23.14% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 29.01 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -39.55% vs 23.27% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 51.81% vs 24.50% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 57.83 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -18.95% vs 23.51% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 38.58% vs 32.10% in Dec 2024

Quarterly - Interest

Interest -0.09 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -115.25% vs -24.36% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -115.00% vs -43.93% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 29.58%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024